APA (7th ed.) Citation

H, S., D, I., O, K., YE, A., U, O., S, O., . . . N, T. (2025). Impact of Age and Menopausal Status on T-DM1 (Ado-Trastuzumab Emtansine) Treatment Outcomes in HER2-Positive Breast Cancer. Pharmaceuticals (Basel, Switzerland), 18(6), . https://doi.org/10.3390/ph18060931

Chicago Style (17th ed.) Citation

H, Surmeli, Isik D, Kinikoglu O, Altintas YE, Ozkerim U, Oksuz S, Basoglu T, Odabas H, and Turan N. "Impact of Age and Menopausal Status on T-DM1 (Ado-Trastuzumab Emtansine) Treatment Outcomes in HER2-Positive Breast Cancer." Pharmaceuticals (Basel, Switzerland) 18, no. 6 (2025). https://doi.org/10.3390/ph18060931.

MLA (9th ed.) Citation

H, Surmeli, et al. "Impact of Age and Menopausal Status on T-DM1 (Ado-Trastuzumab Emtansine) Treatment Outcomes in HER2-Positive Breast Cancer." Pharmaceuticals (Basel, Switzerland), vol. 18, no. 6, 2025, https://doi.org/10.3390/ph18060931.